Application of biomarkers in clinical development of biologics and bioanalytical strategies
10.12092/j.issn.1009-2501.2020.01.004
- VernacularTitle: 生物标志物在生物药临床研究中的应用及生物分析策略
- Author:
Jinjing CHE
1
Author Information
1. Beijing Institution of Pharmacology and Toxicology
- Publication Type:Journal Article
- Keywords:
Bioanalysis;
Biological drugs;
Biomarkers;
Clinical research;
Translational medicine
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2020;25(1):22-31
- CountryChina
- Language:Chinese
-
Abstract:
China's biologic drug research and development is on a fast track lane. The rising cost of new drug development has not improved the success rate of drug launch, and a shift in the model of drug development is urgently needed. In order to improve the success rate, a biomarker strategy of the new drug development model has been proposed and is generally accepted. This paper reviews the research and development of new translational medicine drugs with biomarkers as the core, the application of biomarkers in the clinical study of biological drugs, biomarker biological analysis strategies, and the opportunities and challenges of biomarkers in the clinical study of biological drugs. By comparing international standards, seeking China's advantages and seeking opportunities from the research and development model of translational medicine based on biomarkers, China can make innovative drugs with global influence in the near term.
